Related Experiment Video
Updated: Jun 23, 2026

Applying an Inducible Expression System to Study Interference of Bacterial Virulence Factors with Intracellular Signaling
Published on: June 25, 2015
Induction of cancer cell-specific death via MMP2 promoterdependent Bax expression
Eunjeong Seo1, Sewoon Kim, Eek-hoon Jho
1Department of Life Science, The University of Seoul, Seoul, Korea.
Abstract:
Controlled gene expression in specific cells is a valuable tool for gene therapy. We attempted to determine whether the lentivirus-mediated Tet-On inducible system could be applied to cancer gene therapy. In order to select the genes that induce cancer cell death, we compared the ability of the known pro-apoptotreic genes, Bax and tBid, and a cell cycle inhibitor, p21cip1/waf1, and determined that Bax was the most effective. For the cancer cell-specific expression of rtTA2(S)-M2, we tested the matrix metalloproteinase-2 (MMP-2) promoter and determined that it is highly expressed in cancer cell lines, including SNU475 cells. The co-transduction of two lentiviruses that contain sequences for TRE-Bax and rtTA2(S)-M2, the expression of which is controlled by the MMP-2 promoter, resulted in the specific cell death of SNU475, whereas other cells with low MMP-2 expression did not evidence significant cell death. Our data indicate that the lentivirus-mediated Tet-On system using the cancer-specific promoter is applicable for cancer gene therapy.
Insights
This study shows a lentivirus-mediated Tet-On system can target cancer cells. Using a cancer-specific promoter, it effectively induced cancer cell death, offering a new approach for gene therapy.
Area of Science:
- Biotechnology
- Molecular Biology
- Cancer Research
Background:
- Controlled gene expression is crucial for effective gene therapy.
- The Tet-On inducible system offers a method for regulating gene expression.
- Developing targeted cancer therapies remains a significant challenge.
Purpose of the Study:
- To evaluate the efficacy of a lentivirus-mediated Tet-On system for cancer gene therapy.
- To identify potent pro-apoptotic genes for cancer cell death induction.
- To utilize a cancer-specific promoter for targeted gene delivery.
Main Methods:
- Compared pro-apoptotic genes (Bax, tBid) and a cell cycle inhibitor (p21cip1/waf1) for cancer cell death.
- Assessed the matrix metalloproteinase-2 (MMP-2) promoter for cancer cell-specific expression.
- Co-transduced lentiviruses encoding TRE-Bax and MMP-2 promoter-driven rtTA2(S)-M2.
Main Results:
- Bax was identified as the most effective pro-apoptotic gene.
- The MMP-2 promoter showed high expression in cancer cell lines like SNU475.
- Specific cell death was observed in SNU475 cells, with minimal impact on cells lacking MMP-2 expression.
Conclusions:
- The lentivirus-mediated Tet-On system, combined with a cancer-specific promoter, is a viable strategy for cancer gene therapy.
- Targeted induction of apoptosis in cancer cells is achievable.
- This system demonstrates potential for selective cancer treatment.
Related Concept Videos
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
Apoptosis
Cellular Injury V: Apoptosis and Autophagy
Abnormal Proliferation
Caspases

